Pacmilimab

Pacmilimab (CX-072) is a potent PD-L1 inhibitor. Pacmilimab shows antitumor activity[1].

Product Specifications

CAS Number

[2145091-51-4]

Product Name Alternative

CX-072

UNSPSC

12352203

Target

PD-1/PD-L1

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/pacmilimab.html

Purity

95.00

Solubility

H2O

Smiles

[Pacmilimab]

Molecular Weight

(152.6 kDa)

References & Citations

[1]Naing A, et al. CX-072 (pacmilimab), a Probody ® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072) : an open-label dose-finding and first-in-human study. J Immunother Cancer. 2021 Jul;9 (7) :e002447.

Shipping Conditions

Dry Ice

Storage Conditions

Store at -80°C for 2 years

Scientific Category

Inhibitory Antibodies

Clinical Information

Phase 2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

GTR15351596 1 Vial

Lentiviral human ABCC3 shRNA (UAS) - Lentiviral human ABCC3 shRNA (UAS) (25)

Ask

View Details

HY-141530 1 Each

Clopidogrel-β-D-glucuronide

Ask

View Details

mh32457 500 ng

LentimiRa-Off-hsa-miR-6893-3p Vector

Ask

View Details

SC120058 10 µg

Jagged1 (JAG1) (NM_000214) Human Untagged Clone

Ask

View Details

AP1C289 25 µg

Recombinant Chicken Netrin-1 (NTN1), C-His

Ask

View Details

FAB9305E 0.1 mL

Mouse Monoclonal P2Y11/P2RY11 Antibody (505214) [DyLight 405]

Ask

View Details